About the research trial

Researchers at the InsideOut Institute and Lambert Initiative at the University of Sydney are investigating the safety and efficacy of a new pharmacological treatment, cannabidiol, in persons aged 12-35 with anorexia nervosa.

Cannabidiol is a non-intoxicating component of the Cannabis plant, which is often referred to as CBD. Cannabidiol has been used in clinical trials in young persons (12-25 years) with treatment-resistant anxiety disorders showing very promising results, as well as social anxiety disorder in adults. We want to see if it will help treatment for persons with anorexia nervosa.

Recruitment details

The person may qualify if they:

• Are 12-35 years old
• Have anorexia nervosa
• Are in the care of a medical practitioner
• Are currently under the care of a psychological provider
• Are medically stable

Participation Involves

If the person decides to take part in the research, they will be asked to:

• Have a medical assessment with their GP that will involve blood tests to confirm they are medically stable.
• Take the investigational product, CBD.
• Complete a series of online questionnaires throughout treatment and at 3 months after treatment ends.

The CBD treatment will last 12 weeks.

Your participation to participate in research is voluntary.

Reimbursement for participation:

• You will receive the investigational product, CBD, at no expense to you.
• You will need to be assessed by your GP for medical stability prior to participation and during participation. Appointments with your GP are at your own cost.
• There are no other costs associated with participation in this research study, nor will you be paid.

If the person would like to register their interest, they can complete our pre-screening questionnaire here: CAFTAN STUDY QUESTIONNAIRE

You can also visit our trial website caftanstudy.com.au for additional details and resources